TY - STD TI - Initial draft discussion document for a Canadian orphan drug regulatory framework. Health Canada, Office of Legislative and Regulatory Modernization. 2012. http://www.orpha.net/national/data/CA-EN/www/uploads/Initial-Draft-Discussion-Document-for-A-Canadian-Orphan-Drug--Regulatory-Framework.doc. Accessed 1 Dec 2015. UR - http://www.orpha.net/national/data/CA-EN/www/uploads/Initial-Draft-Discussion-Document-for-A-Canadian-Orphan-Drug--Regulatory-Framework.doc ID - ref1 ER - TY - STD TI - Critchley W. Orphan drugs update – Canada. Presented at: FDLI Conference. 2014 May 14–15; Toronto, CA. http://www.fdli.org/docs/canadian/critchley-fdli-may-14-2014.pdf?sfvrsn=0. Accessed 1 Dec 2015. UR - http://www.fdli.org/docs/canadian/critchley-fdli-may-14-2014.pdf?sfvrsn=0 ID - ref2 ER - TY - JOUR AU - Lee, D. K. AU - Wong, B. PY - 2014 DA - 2014// TI - An Orphan Drug Framework (ODF) for Canada JO - J Popul Ther Clin Pharmacol VL - 21 ID - Lee2014 ER - TY - STD TI - Electronic code of federal regulations title 21 food and drugs part 316 orphan drugs. U.S. Government Publishing Office. http://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&SID=238362420de6b80c19b2a9c44b73a843&rgn=div6&view=text&node=21:5.0.1.1.6.3&idno=21. Accessed 1 Dec 2015. UR - http://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&SID=238362420de6b80c19b2a9c44b73a843&rgn=div6&view=text&node=21:5.0.1.1.6.3&idno=21 ID - ref4 ER - TY - STD TI - Search orphan drug designations and approvals. U.S. Food and Drug Administration. www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm. Accessed 28 Jul 2014. UR - http://www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm ID - ref5 ER - TY - STD TI - Gibson S, von Tigerstrom B. Orphan drug incentives in the pharmacogenomic context: policy responses in the US and Canada. J Law Biosci. 2015;2:263–91. ID - ref6 ER - TY - JOUR AU - Hall, A. K. AU - Carlson, M. R. PY - 2014 DA - 2014// TI - The current status of orphan drug development in Europe and the US JO - Intractable Rare Dis Res VL - 3 UR - https://doi.org/10.5582/irdr.3.1 DO - 10.5582/irdr.3.1 ID - Hall2014 ER - TY - STD TI - Harper government takes action to help Canadians with rare diseases – launch of first ever Canadian framework to increase access to new treatments and information and Orphanet-Canada Portal – news release. Government of Canada. 2012. http://news.gc.ca/web/article-en.do?nid=698449. Accessed 1 Dec 2015. UR - http://news.gc.ca/web/article-en.do?nid=698449 ID - ref8 ER - TY - JOUR AU - Douglas, C. M. AU - Wilcox, E. AU - Burgess, M. AU - Lynd, L. D. PY - 2015 DA - 2015// TI - Why orphan drug coverage reimbursement decision-making needs patient and public involvement JO - Health Policy VL - 119 UR - https://doi.org/10.1016/j.healthpol.2015.01.009 DO - 10.1016/j.healthpol.2015.01.009 ID - Douglas2015 ER - TY - STD TI - Notice of Compliance (NOC) database. Health Canada. 2014. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/notices-avis/index-eng.php. Accessed 1 Jul 2014. UR - http://www.hc-sc.gc.ca/dhp-mps/prodpharma/notices-avis/index-eng.php ID - ref10 ER - TY - STD TI - IMS Midas. IMS Health. http://www.imshealth.com/en/solution-areas/technology-and-applications/offerings/midas. Accessed 1 Dec 2015. UR - http://www.imshealth.com/en/solution-areas/technology-and-applications/offerings/midas ID - ref11 ER - TY - STD TI - Therapeutic categories outlook. Cowen and Company. 2014. http://www.cowen.com/cowen-and-company/. UR - http://www.cowen.com/cowen-and-company/ ID - ref12 ER - TY - STD TI - Consumer price index, historical summary (1995 to 2014). Statistics Canada. 2015. http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/econ46a-eng.htm. Accessed 11 Feb 2015. UR - http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/econ46a-eng.htm ID - ref13 ER - TY - STD TI - Market Prognosis 2014–2018, Canada. IMS Health. 2014. http://customerportal.imshealth.com/portal/site/imsportal. UR - http://customerportal.imshealth.com/portal/site/imsportal ID - ref14 ER - TY - STD TI - National Health Expenditure Trends, 1975 to 2013. Canadian Institute for Health Information (CIHI). 2013. https://secure.cihi.ca/free_products/NHEXTrendsReport_EN.pdf. Accessed 27 Jan 2016. UR - https://secure.cihi.ca/free_products/NHEXTrendsReport_EN.pdf ID - ref15 ER - TY - STD TI - Environmental scan – drugs for rare diseases: evolving trends in regulatory and health technology assessment perspectives. Canadian Agency for Drugs and Technologies in Health (CADTH). 2014. https://www.cadth.ca/media/pdf/ES0281_RareDiseaseDrugs_es_e.pdf. Accessed 1 Dec 2015. UR - https://www.cadth.ca/media/pdf/ES0281_RareDiseaseDrugs_es_e.pdf ID - ref16 ER - TY - JOUR AU - Hutchings, A. AU - Schey, C. AU - Dutton, R. AU - Achana, F. AU - Antonov, K. PY - 2014 DA - 2014// TI - Estimating the budget impact of orphan drugs in Sweden and France 2013–2020 JO - Orphanet J Rare Dis VL - 9 UR - https://doi.org/10.1186/1750-1172-9-22 DO - 10.1186/1750-1172-9-22 ID - Hutchings2014 ER - TY - JOUR AU - Kanters, T. A. AU - Steenhoek, A. AU - Hakkaart, L. PY - 2014 DA - 2014// TI - Orphan drugs expenditure in the Netherlands in the period 2006–2012 JO - Orphanet J Rare Dis VL - 9 UR - https://doi.org/10.1186/s13023-014-0154-0 DO - 10.1186/s13023-014-0154-0 ID - Kanters2014 ER - TY - JOUR AU - Denis, A. AU - Mergaert, L. AU - Fostier, C. AU - Cleemput, I. AU - Simoens, S. PY - 2010 DA - 2010// TI - Budget impact analysis of orphan drugs in Belgium: estimates from 2008 to 2013 JO - J Med Econ VL - 13 UR - https://doi.org/10.3111/13696998.2010.491427 DO - 10.3111/13696998.2010.491427 ID - Denis2010 ER - TY - JOUR AU - Schey, C. AU - Milanova, T. AU - Hutchings, A. PY - 2011 DA - 2011// TI - Estimating the budget impact of orphan medicines in Europe: 2010–2020 JO - Orphanet J Rare Dis VL - 6 UR - https://doi.org/10.1186/1750-1172-6-62 DO - 10.1186/1750-1172-6-62 ID - Schey2011 ER - TY - STD TI - Facts about Generics. FDA. 2015. http://www.fda.gov/drugs/resourcesforyou/consumers/buyingusingmedicinesafely/understandinggenericdrugs/ucm167991.htm. Accessed 24 Mar 2016. UR - http://www.fda.gov/drugs/resourcesforyou/consumers/buyingusingmedicinesafely/understandinggenericdrugs/ucm167991.htm ID - ref21 ER -